Weight Loss Study

Ichor Research is running a clinical trial that will compare an investigational GLP-1 drug to an approved GLP-1 therapy. Overweight adults who are committed to losing 25% of their body weight may be eligible to participate.

This trial will test an investigational GLP-1 drug to see if it can help support weight reduction in overweight adults.

As part of this clinical study, all participants will receive counseling on diet and exercise to help support weight loss.

This clinical trial is being sponsored by Novo Nordisk. Because the investigational treatment is being compared to an approved medicine, all participants will receive an active drug (either an investigational GLP-1 drug, or an approved GLP-1 treatment).

To learn more about this study, complete this form. If this trial looks like a good fit for you, a study team member will reach out to you promptly.

The purpose of the questionnaire is to see if this study is a good fit for you. When you submit a form, your answers will be stored in a HIPAA-compliant, encrypted database. Even if this study is not a good fit for you, your data will be stored so that we can match you to other clinical studies in the future. By submitting this form, you give Ichor Research permission to store your responses for these purposes and contact you for future study opportunities.